Skip to content
BC

Boston Commerce

531458 BSE
Price unavailable

Boston Commerce (BOSTON) share price was ₹11.00 at the 28 Oct 2026 close; market capitalisation ₹7.67 Cr; sector Healthcare Services. The share price rose 43.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was under ₹0.01 Cr, against ₹0.19 Cr a year earlier and net profit was −₹0.65 Cr, against −₹0.49 Cr a year earlier (compared with Mar 2025). Promoters held 2.14% of Boston Commerce in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 58/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹11.00 +3.00 +37.50% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹7.67 Cr
EBITDA
−₹6.60 Cr
Return on Equity
564.38%
Debt to Equity
1.53
Book Value
−₹1.82
EPS (TTM)
−₹0.82
52W High
₹11.05
52W Low
₹4.01

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,906.5058.9532,000 Cr12.760.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,438.9078.9314,820 Cr15.480.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹549.1056.4311,388 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹514.6546.458,191 Cr15.982.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹318.5546.301,659 Cr6.780.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹496.0516.271,609 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Boston Commerce (this company)
——8 Cr—0.00%564.38%517.80%1 Cr-1 Cr
Median 8 companies₹549.1056.437,265 Cr7.580.21%15.49%17.48%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

58 Good
Overall score

Data confidence 86/100

Category scores

Quality Good 57
Returns, margins, earnings quality 22% weight
Valuation Average 50
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Poor 17
Solvency, leverage, coverage 9% weight
Momentum Strong 99
Trend strength, vol-adjusted 12% weight
Ownership Good 58
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding is low: 2.14%
  • Company has a low return on equity of -52.4% over last 3 years.
  • Company's cost of borrowing seems high

Technical Indicators

Oscillators

Bearish

Bearish
6
Neutral
1
Bullish
2

Overall

Bullish

Bearish
6
Neutral
1
Bullish
12

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
150%

change over 1 year

Cash Flow Change
196%

change over 1 year

EBITDA Margin Change
379%

change over 1 year

Quarterly Results

Particulars Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
0
0
0
0
0
0
0
0
0.19
0.18
0.24
0.06
0
Expenses
0
0
0
0
0.14
0
0.01
0.05
0.68
0.1
0.14
0.04
0.08
Operating Profit
0
0
0
0
-0.14
0
-0.01
-0.05
-0.49
0.08
0.1
0.02
-0.08
OPM %
—
—
—
—
—
—
—
—
-257.89%
44.44%
41.67%
33.33%
—
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0.03
0.05
0.03
0.59
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
-0.14
0
-0.01
-0.05
-0.49
0.05
0.05
-0.01
-0.67
Tax %
—
—
—
—
0%
—
0%
0%
0%
20%
20%
0%
-4.48%
Net Profit
0
0
0
0
-0.14
0
-0.01
-0.05
-0.49
0.04
0.04
-0.01
-0.65
EPS (₹)
0
0
0
0
-0.2
0
-0.01
-0.07
-0.7
0.06
0.06
-0.01
-0.93
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0.12
0.15
0.05
0.06
1.5
0.53
0.7
0
0
0
0.19
0.48
Expenses
0.27
0.16
0.05
0.06
1.5
0.53
0.7
0
0
0.14
0.74
7.07
Operating Profit
-0.15
-0.01
0
0
0
0
0
0
0
-0.14
-0.55
-6.59
OPM %
-125%
-6.67%
0%
0%
0%
0%
0%
—
—
—
-289.47%
-1372.92%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0.59
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.15
-0.01
0
0
0
0
0
0
0
-0.14
-0.55
-7.18
Tax %
0%
0%
—
—
—
—
—
—
—
0%
0%
0%
Net Profit
-0.15
-0.01
0
0
0
0
0
0
0
-0.14
-0.55
-7.18
EPS (₹)
-0.21
-0.01
0
0
0
0
0
0
0
-0.2
-0.79
-10.25
Div. Payout %
0%
0%
—
—
—
—
—
—
—
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7
7
7
7
7
7
7
7
7
7
7
7
Reserves
-0.4
-0.4
-0.4
-0.4
-0.4
-0.4
-0.4
-0.41
-0.41
-0.55
-1.1
-8.27
Borrowings
0.14
0.12
0.12
0.12
0.87
0.87
0.87
0.87
0.87
0.87
5.44
1.66
Other Liabilities
0
-0.01
-0.01
-0.01
1.46
1.9
2.6
3.11
3.11
3.25
3.57
0.37
Total Liabilities
6.74
6.71
6.71
6.71
8.93
9.37
10.07
10.57
10.57
10.57
14.91
0.76
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
6.74
6.71
6.71
6.71
8.93
9.37
10.07
10.57
10.57
10.57
14.91
0.76
Total Assets
6.74
6.71
6.71
6.71
8.93
9.37
10.07
10.57
10.57
10.57
14.91
0.76
Figures in ₹ Crores

Cash Flow

Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
0
0
0.97
-0.03
-0.02
0.13
0
0
0
-4.59
4.42
Investing
0
0
0
-0.91
0
0
-0.08
0
0
0
0
0
Financing
-1
0
0
0
0
0
0
0
0
0
4.58
-4.38
Net Cash Flow
0
0
0
0.06
-0.03
-0.02
0.05
0
0
0
-0.01
0.04
Free Cash Flow
1
0
0
0.97
-0.03
-0.02
0.13
0
0
0
-4.59
4.42
CFO/OP
-667
0
—
—
—
—
—
—
—
0
835
-67
Figures in ₹ Crores

Ratios

Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
0
0
363
1,343
1,309
—
—
—
5,533
0
Inventory Days
0
0
—
—
0
0
11.59
—
—
—
—
0
Days Payable
—
—
—
—
—
—
1,489
—
—
—
—
—
Cash Conversion Cycle
0
0
0
0
363
1,343
-169
—
—
—
5,533
0
Working Capital Days
-426
-292
-876
4,745
226
661
454
—
—
—
10,585
236
ROCE %
-2.05%
-0.15%
0%
0%
0%
0%
0%
—
0%
-1.89%
-5.89%
-112.36%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Boston Commerce insights

60 extracted metrics + investor summaries across FY00–FY26.

Shareholding Pattern

DIIs2.13%Public80.95%Promot.2.14%Others14.78%As ofSep 2026

Documents

Frequently Asked Questions about Boston Commerce

What does Boston Commerce Limited do?
Incorporated in 1995, Boston Bio Systems Ltd is in the business of trading in goods e.g. Medical equipment, testing kits, instruments etc.[1]
Where is Boston Commerce Limited (BOSTON) listed?
Boston Commerce Limited trades under code 531458 on the BSE.
Which sector does Boston Commerce Limited belong to?
Boston Commerce Limited is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Boston Commerce Limited?
Boston Commerce Limited has a market capitalisation of ₹7.67 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Boston Commerce Limited?
Over the last 52 weeks Boston Commerce Limited has traded between ₹4.01 and ₹11.05 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Boston Commerce Limited?
Boston Commerce Limited reported a return on equity of 564.38%. Its debt-to-equity ratio is 1.53.

Company Information

Incorporated in 1995, Boston Bio Systems Ltd is in the business of trading in goods e.g. Medical equipment, testing kits, instruments etc.[1]

Website bostonbiosystemltd.com
Face Value ₹ 10
Shares Outstanding 69,72,112

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531458.md for Boston Commerce Limited: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month